Will the COVID antiviral medications be the Thor’s Hammer against SARS-CoV-2 and help mitigate the ravages of the pandemic? These are impressive drugs but there are logistical, social, geographical, and financial caveats to solve in the process. November 24, 2021November 24, 2021Dr. Barry Dworkin Medical Mythbusting Commentary for November 24, 2021 [display_podcast] Source:How Will the COVID Pills Change the Pandemic? Related posts: British chief medical officer warns of increasing antibiotic-resistant bacteria Bacterial antibiotic drug resistance is a major health issue and is not abating. Changes to agricultural and medical policy among other strategies are required to mitigate this trend. Health Canada’s approval of SARS-CoV-2 antibody test has its limitations but is a good first step to prepare for the easing of restrictions. Public health policy decisions will depend on its availability in significant quantity. Why proposing “herd immunity” as a strategy by using SARS-CoV-2 as your inoculating vector is not a good idea. Historically, there has never been a real case of herd immunity through infection. Covid-19molnupiravir